Mallinckrodt PLC ( MNK) as of Wed, Nov 22, 2017

Sections on this page: Stock Price | Stock Charts | Company Profile | Earnings

MNK Stock Price Today $21.37

 The recent MNK stock price today is $21.37 -0.02 (-0.09%) for Wed, Nov 22, 2017.

Year To Date

The Year To Date (YTD) return is -58.69%.

52 Week Low

The 52 Week Low stock price is 19.00 set on Tue, Nov 7, 2017 which is 15 days ago.

The current price per share is 12.47% above the 52 week low.

52 Week High

The 52 Week High stock price is $58.09 set on Mon, Nov 28, 2016 which is 359 days ago.

The current price per share is -63.21% below the 52 week high.

All Time High

The All Time High stock price is $134.26 set on Mon, Mar 23, 2015 which is 975 days ago.

The current price per share is -84.08% below the all time high.

Mallinckrodt Stock Charts

The 5 year and 1 year stock charts are below.

5 Year Stock Chart

The Mallinckrodt 5 year stock chart shows the historical prices over the previous 60 months.

Mallinckrodt 5 year stock chart

1 Year Stock Chart

The Mallinckrodt 1 year stock chart shows the historical prices over the previous 12 months.

Mallinckrodt 1 year stock chart

50 Day Moving Average

The 50 Day Moving Average is at $42.58 which is 49.81% above the stock price of $21.37.

200 Day Moving Average

The 200 Day Moving Average is at 47.40 which is 54.92% above the stock price of $21.37.

MNK Company Profile

Mallinckrodt PLC LogoMallinckrodt PLC is a Health Care stock that trades on the NYSE and has a market capitalization of $2.07 Billion.

http://www.mallinckrodt.comMallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

For more information and analysis about Mallinckrodt PLC, visit their web site at http://www.mallinckrodt.com. For a real time price lookup on this ticker, MNK, visit Google Finance and Bloomberg.

Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .

MNK Earnings

 Below is the EPS, P/E Ratio and Earnings Date.

Earnings Per Share

The EPS is -$0.02 and the P/E Ratio is 0.

Earnings Dates

The Earnings Release Date was Tue, Aug 8, 2017.

Since this earnings release 106 days ago, the stock price is down by -47.79%.

The most recent Earnings Release Date was on Tue, Nov 7, 2017, which was 15 days ago.

Since this earnings date, the stock price is down by -31.46%.

Mallinckrodt Dividend

MNK currently does not pay a dividend.